BrainCheck, Inc.

BrainCheck is a software platform for cognitive assessment and care planning, headquartered in Austin, Texas with operations in New York City. The company develops FDA-registered Class II digital cognitive assessment tools designed to integrate into clinical workflows for neurologists, psychiatrists, primary care providers, and clinical researchers. BrainCheck Assess, the platform's flagship product, is a 15-minute cognitive evaluation spanning five domains that detects subtle signs of cognitive impairment, potentially associated with dementias including Alzheimer's disease. The platform comprises 30+ clinical evaluation tools including validated screeners, assessments, and surveys. Published peer-reviewed research demonstrates that BrainCheck Assess scores correlate highly with the Montreal Cognitive Assessment (MoCA, r=0.77) and can distinguish between normal cognition, mild cognitive impairment, and dementia with high sensitivity and specificity. The platform supports seamless integration with major electronic health record systems (Epic, athenahealth) to enable cognitive screening, assessment, interpretation, care planning, and follow-up within routine care. BrainCheck's clinical validation is supported by a normative database of 5,000+ patients and real-world data from 450,000+ patient assessments. The company collaborates with leading academic and research institutions including University of Texas at Austin, Johns Hopkins University, Mount Sinai, Stanford University, and MD Anderson Cancer Center. U.S.-based clinical and technical support is available for product use, documentation, and billing inquiries.